20 July 2018
Australian biomedical innovation training programs have been recognised on a global stage, with Team Australia invited by the founders of the Stanford SPARK program to present at the SPARK Global meeting in Berlin, Germany.
17 July 2018
Five digital health companies have been announced as the successful applicants for ANDHealth+ 2018, Australia’s only mid-stage digital health, market and investment readiness program.
11 July 2018
Following the launch earlier this year of a new professional development program for commercialising medical devices, the BridgeTech Program is now announcing the official consortium of partners and the selection of its first cohort.
10 July 2018
ARCS Australia are also very pleased to announce the continuation of the MTPConnect MOU.
10 July 2018
Eight promising medtech companies receive seed funding, training and mentoring from venture-backed national accelerator: The Actuator
The Actuator are thrilled to announce the eight high-impact medtech startups that are part of the 2018 Round 2 Actuator Accelerator program: TerraBlue XT, Curatek, Stelect, Augmented Bionics, ElectroAutoMedics, Flomatrix, Hexagon Innovation and Lenexa Medical.
08 July 2018
Wound Innovations, the Wound Management Innovation CRC’s spin out company, has today publicly launched its greatly anticipated Wound Clinician Credentialing program and associated national register of credentialed wound clinicians.
06 July 2018
Over 300 representatives of the Australian biotechnology sector formed the Australian delegation at the 2018 BIO International Convention, led by AusBiotech in partnership with MTPConnect and Austrade.
03 July 2018
MTPConnect in conjunction with the Western Australian Government and The University of Western Australia (UWA), is delighted to announce the establishment of the Western Australian Node (the WA Node) of MTPConnect in Perth, to support the state’s burgeoning life sciences sector.
02 July 2018
South Australian researchers are embarking on a $20 million medical and manufacturing research project which could reduce the chance of infection after orthopaedic surgery, thanks to a little help from the humble dragonfly.
29 June 2018
International Clinical Trials Day, held in May, commemorates Lind’s trials into the causes of scurvy and recognises that clinical trials are central to discovering and proving the efficacy of new treatments. But we’ve come a long way since 1747.
26 June 2018
The Wound Management Innovation Cooperative Research Centre (Wound CRC) completes its funding term at the end of this month, and with this comes one of the most significant legacies – Federal Government acknowledgement and response to the national wounds problem.
19 June 2018
Diabetic foot disease (DFD) is globally recognised as the leading cause of all lower-limb amputations, and in Australia alone, it results in 4,400 amputations, 27,600 hospitalisations and nearly 1,700 deaths each year.
07 June 2018
CCRM Australia and Therapeutic Innovation Australia collaborate to develop an information system for regenerative medicine
The Centre for Commercialization of Regenerative Medicine Australia (CCRM Australia) is proud to partner with Therapeutic Innovation Australia (TIA) to jointly develop an information system to curate data on the Australian regenerative medicine sector and to serve as both CCRM Australia’s customer relationship management and project management platforms.
31 May 2018
Novel solutions for biofilm infections are the focus of a collaborative research agreement between the University of Sydney, Whiteley Corporation and the Innovative Manufacturing Cooperative Research Centre (IMCRC).
29 May 2018
Proteomics International signs deal with PrismHealthDx to launch PromarkerD predictive test for diabetic kidney disease in USA
Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) has signed the first licence agreement for its world-leading PromarkerD predictive test for diabetic kidney disease in the United States, creating a partnership with US-based precision medicine and diagnostic services laboratory PrismHealthDx, Inc. (PHDx).